Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

NCT00698932 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

568

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Saxagliptin
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]